ALHC Alignment Health: רווח נקי למניה ב-12 החודשים האחרונים

Is it worth investing in Alignment Healthcare (ALHC), given its expansion in the Medicare Advantage segment? Growth is driven by an aging population, the AVA AI system, and a high quality rating, while historical year-over-year EPS growth (TTM) confirms the trend, where the current mark equals 225.20. However, the survival of independent plans is complicated by aggressive dumping from systemic healthcare behemoths.

To build a high-quality portfolio, I track earnings per share dynamics, where this indicator measures the percentage change in trailing twelve-month (TTM) income, reflecting the actual efficiency of the business capitalization. In the case of Alignment Healthcare (ALHC), this calculation allows for an assessment of how the implementation of the AVA AI platform and predictive analytics converts into profit growth, which is clearly confirmed by the historical year-over-year EPS growth (TTM).